Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBTC Study 27: Moxifloxacin in Pulmonary Tuberculosis
NCT00140309Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Jul 2003
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of moxifloxacin in pulmonary tuberculosis (TB), sponsored by Centers for Disease Control and Prevention. Started Jul 2003; status: completed.
02
Drugs
moxifloxacin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00140309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140309.